CNS Drugs

Over-the-Counter Triptans for Migraine: What are the Implications?
pp. 877-883(7)
Authors: Tfelt-Hansen, Peer; Steiner, Timothy J.

Agmatine: Metabolic Pathway and Spectrum of Activity in Brain
pp. 885-900(16)
Authors: Halaris, Angelos; Plietz, John

Long-Term and Preventative Treatment for Seasonal Affective Disorder
pp. 901-909(9)
Authors: Westrin, Åsa; Lam, Raymond W.

Adverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications
pp. 911-936(26)
Authors: Haddad, Peter M.; Sharma, Sonu G.

Preliminary Efficacy Report of a Novel Thrombolytic Agent for Acute Ischaemic Stroke within a 5-Hour Window
pp. 937-946(10)
Authors: Chao, A-Ching; Teng, Michael Mu-Huo; Chung, Chih-Ping; Weng, Hsing-Yu; Chen, Yen-Yu; Yang, Fu-Yi; Wang, Lee-Min; Hu, Han-Hwa

An Approach to Reduce Benzodiazepine and Cyclopyrrolone Use in General Practice: A Study Based on a Danish Population
pp. 947-955(9)
Authors: Jørgensen, Viggo R.K.

Rivastigmine Transdermal Patch: In the Treatment of Dementia of the Alzheimer's Type
pp. 957-965(9)
Authors: Yang, Lily P.H.; Keating, Gillian M.